Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|April 22, 2020
Chemic Laboratories, Inc.
Author(s)Chemic Laboratories, Inc.
Chemic Laboratories, Inc. is a full service cGMP/ GLP contract analytical chemistry laboratory.
Chemic Laboratories, Inc. is a full service cGMP/ GLP contract analytical chemistry laboratory. Chemic provides an array of R&D and cGMP contract testing services including; Extractables/Leachables analysis, CMC Method Development & Validation, Quality Control analysis, Release testing, Raw Materials analysis, Compendial testing, Organic Synthesis/Formulation Development & ICH Stability testing.
INTERPHEX Booth # 1367
Chemic Laboratories, Inc.
480 Neponset St., Building 7, Canton, MA 02021
tel. 781.821.5600
fax 781.821.5651
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
3
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
4
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
5